TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9470865

Group type: EXPERIMENTAL
Intervention: New procedures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedural treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticoagulation regimens for coronary stents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-randomised studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis of large clinical series
Number of subjects: 0
Study: 7929695

Group type: EXPERIMENTAL
Intervention: High-dose IL-1 alpha (3.0 micrograms/m2/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low-dose IL-1 alpha (0.1, 0.3, or 1.0 microgram/m2/day)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-dose IL-1 alpha
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low-dose IL-1 alpha
Number of subjects: 29
Study: 3282911

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg x 3 daily for patients <30 kg or 400 mg x 2 daily for patients >30 kg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 29635419

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 4262

Group type: COMPARATOR
Intervention: Control (no BCG vaccine)
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in children with BCG-vaccinated mothers
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in children with non-BCG-vaccinated mothers
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in children born by cesarean section
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in other children (not born by cesarean section)
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in premature children
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: BCG vaccine in children born at term
Number of subjects: 4262
Study: 28560328

Group type: EXPERIMENTAL
Intervention: Off-grid solar power
Number of subjects: 1281
Study: 26923690

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment and exercise therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo ultrasound treatment and exercise therapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment
Number of subjects: 52
Study: 25262458

Group type: EXPERIMENTAL
Intervention: StopAdvisor
Number of subjects: 4613

Group type: COMPARATOR
Intervention: Information-only website
Number of subjects: 4613
Study: 22034523

Group type: EXPERIMENTAL
Intervention: Peppermint spirits inhalation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo aromatherapy (inert placebo, green-colored sterile water)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard antiemetic therapy (intravenous ondansetron or promethazine suppositories)
Number of subjects: 35
Study: 19733206

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate (0.06% chlorhexidine, pH 6.0, Periogard‐Colgate, Brazil)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.61% green tea extract solution (OM24, 100% Camellia Sinensis leaf extract, catechin concentration: 30+/‐3%, pH 7.0, Omnimedica, Switzerland)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluoride-free toothpaste and electrical toothbrush (F)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Deionized water (control)
Number of subjects: 12
Study: 17452070

Group type: EXPERIMENTAL
Intervention: 30-min training course for cardiopulmonary resuscitation and automated external defibrillator use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional multi-hour Heartsaver-AED training
Number of subjects: 0
Study: 15629993

Group type: EXPERIMENTAL
Intervention: Registry-based reminder/recall letters (up to 3 letters)
Number of subjects: 5193

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 5193
Study: 11907288

Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg daily for six weeks)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 10206519

Group type: EXPERIMENTAL
Intervention: Digital hearing aid with compression and noise reduction
Number of subjects: 27

Group type: COMPARATOR
Intervention: Analogue reference aids
Number of subjects: 27
Study: 7605928

Group type: EXPERIMENTAL
Intervention: Neurons related to overt speech (Type A neurons) during verbal paired associates learning
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Neurons not related to language or memory (Type D neurons) during exposure to unlearned word pairs
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All groups of neurons during practice
Number of subjects: 49
Study: 2404097

Group type: EXPERIMENTAL
Intervention: Exogenous surfactant therapy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham (air) therapy
Number of subjects: 94
Study: 850579

Group type: EXPERIMENTAL
Intervention: ACFUCY combination (Actinomycin‐D, 5‐fluorouracil, and cyclophosphamide)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Melphalan
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: ACFUCY combination
Number of subjects: 108
Study: 31610152

Group type: EXPERIMENTAL
Intervention: White women before menopause
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Black women before menopause
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: White women postmenopause
Number of subjects: 94

Group type: COMPARATOR
Intervention: Black women postmenopause
Number of subjects: 94
Study: 30191995

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 286

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 286
Study: 27432356

Group type: EXPERIMENTAL
Intervention: COBRA Classic (MTX + sulfasalazine + prednisone step-down from 60 mg)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: COBRA Slim (MTX + prednisone step-down from 30 mg) high risk
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: COBRA Avant Garde (MTX + leflunomide + prednisone step-down from 30 mg)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: MTX tight step-up (MTX-TSU)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: COBRA Slim (low risk)
Number of subjects: 379
Study: 25187182

Group type: EXPERIMENTAL
Intervention: Pain diary intervention measuring pain intensity, location, duration, affective ratings, and coping responses
Number of subjects: 95
Study: 23869186

Group type: EXPERIMENTAL
Intervention: Echogenic needle (Group E)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-echogenic needle (Group N)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non-echogenic needle with nerve stimulator (Group NS)
Number of subjects: 90
Study: 21867532

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES) Therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (non-NMES)
Number of subjects: 41
Study: 19152514

Group type: EXPERIMENTAL
Intervention: 20% ALA-based photodynamic therapy (PDT) applied for 4 hours, followed by excimer-dye laser exposure at 630 nm at a dose of 50 J/cm² three times at 7-day intervals.
Number of subjects: 30
Study: 17904980

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancies (preeclampsia or gestational hypertension) at 35 weeks
Number of subjects: 4293

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancies (preeclampsia or gestational hypertension) at 36 weeks
Number of subjects: 4293

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancies (preeclampsia or gestational hypertension) at 37 weeks
Number of subjects: 4293
Study: 15383382

Group type: EXPERIMENTAL
Intervention: Three-second wait time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Six-second wait time
Number of subjects: 0
Study: 11498597

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9571555

Group type: EXPERIMENTAL
Intervention: Topical aqueous indomethacin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical ketorolac
Number of subjects: 120
Study: 7918070

Group type: EXPERIMENTAL
Intervention: AML/TMDS
Number of subjects: 230

Group type: COMPARATOR
Intervention: AML without TMDS
Number of subjects: 230

Group type: COMPARATOR
Intervention: Absence of TMDS in AML
Number of subjects: 230
Study: 2963192

Group type: EXPERIMENTAL
Intervention: Glipizide
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 31296738

Group type: EXPERIMENTAL
Intervention: Microbiota-directed complementary food (MDCF) prototypes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 28363318

Group type: COMPARATOR
Intervention: Pamphlet (N=25)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Computer (N=24)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Computer+Mastery (N=27)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 76
Study: 26588688

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 344

Group type: COMPARATOR
Intervention: Traditional scalpel
Number of subjects: 344
Study: 24057426

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine plus hydromorphone 100 μg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine alone
Number of subjects: 88
Study: 22289547

Group type: EXPERIMENTAL
Intervention: 5 ml normal saline
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: 5 ml normal saline containing adrenaline (5 μg/ml)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Direct epidural catheter placement
Number of subjects: 295
Study: 19842005

Group type: EXPERIMENTAL
Intervention: Perceived discrimination (DAS scale) in US-born Latinos
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Report of any doctor or medical staff discrimination in foreign-born Latinos
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Doctor discrimination and higher DAS in US-born Latinos
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Discrimination on doctor-patient communication in foreign-born Latinos
Number of subjects: 1067
Study: 16672731

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory‐II (BDI‐II)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Three-factor solution (somatic, affective, and cognitive)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Somatic symptoms
Number of subjects: 598
Study: 15636218

Group type: EXPERIMENTAL
Intervention: Patients with senile cataract
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Patients with diabetic cataract
Number of subjects: 3

Group type: COMPARATOR
Intervention: Healthy adults (without cataract and without diabetes mellitus)
Number of subjects: 3
Study: 11404645

Group type: EXPERIMENTAL
Intervention: Multisite randomized controlled trials (RCTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 9728121

Group type: EXPERIMENTAL
Intervention: Stabilization appliance
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control appliance
Number of subjects: 58
Study: 7956269

Group type: EXPERIMENTAL
Intervention: Good description (G) of assignment methods
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fair description (F) of assignment methods
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Poor description (P) of assignment methods
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: No description (N) of assignment methods
Number of subjects: 200
Study: 2738227

Group type: EXPERIMENTAL
Intervention: Systematic programme of nursing support in addition to routine care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 60
Study: 31439336

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg dual therapy
Number of subjects: 2725

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg dual therapy
Number of subjects: 2725

Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study: 26446728

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon Angioplasty (DCBA)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard Balloon Angioplasty (POBA)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: DCBA
Number of subjects: 119

Group type: COMPARATOR
Intervention: POBA
Number of subjects: 119
Study: 22549238

Group type: EXPERIMENTAL
Intervention: 0.1% taprenepag isopropyl monotherapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.1% taprenepag isopropyl in combination with 0.005% latanoprost
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.1% taprenepag isopropyl monotherapy and combination therapy
Number of subjects: 32
Study: 21653650

Group type: EXPERIMENTAL
Intervention: 6-PACK programme (12 wards)
Number of subjects: 16000

Group type: COMPARATOR
Intervention: Usual care control group (12 wards)
Number of subjects: 16000
Study: 19114073

Group type: EXPERIMENTAL
Intervention: L. casei rhamnosus
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Multi-species probiotic
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: L. rhamnosus T cell-1
Number of subjects: 1062
Study: 17020889

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (sirolimus or paclitaxel-eluting)
Number of subjects: 8221

Group type: COMPARATOR
Intervention: Bare metal stents
Number of subjects: 8221

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 8221

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 8221
Study: 15369608

Group type: EXPERIMENTAL
Intervention: Plasma levels of six carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein, zeaxanthin)
Number of subjects: 3043
Study: 12771983

Group type: EXPERIMENTAL
Intervention: Parents who lost a child with incident cancer
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Unexposed parents with incident cancer
Number of subjects: 1630
Study: 11094663

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8815853

Group type: EXPERIMENTAL
Intervention: PROPATH Program
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual medical care only
Number of subjects: 46
Study: 1563059

Group type: EXPERIMENTAL
Intervention: Amrinone, 0.75 mg.kg‐1, administered ten minutes before separation from cardiopulmonary bypass (CPB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 100
Study: 3890520

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 3068365

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (exact drugs not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: WOMAC instrument
Number of subjects: 0
Study: 31837291

Group type: EXPERIMENTAL
Intervention: Complex intervention involving training for family physicians on contraceptive effectiveness counselling and access to rapid referral to long-acting reversible contraceptive insertion clinics.
Number of subjects: 740

Group type: COMPARATOR
Intervention: Control group (usual contraception counselling without intervention).
Number of subjects: 740
Study: 31286871

Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) program
Number of subjects: 260

Group type: COMPARATOR
Intervention: Conventional management of pain (before medical staff training to TPE)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Educational approach by health providers trained to TPE
Number of subjects: 260
Study: 28455321

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 183
Study: 25771759

Group type: EXPERIMENTAL
Intervention: Forearm tourniquet IVRA with 10 mL of 0.5% lidocaine and 30 mL of 0.25% lidocaine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional upper arm tourniquet IVRA with 40 mL of 0.5% lidocaine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Forearm tourniquet IVRA
Number of subjects: 32
Study: 24210183

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy followed by delayed nephrectomy
Number of subjects: 525

Group type: COMPARATOR
Intervention: Immediate nephrectomy
Number of subjects: 525
Study: 21739695

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at left Hegu (LI 4)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at left Dicang (ST 4)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Electroacupuncture at left Houxi (SI 3)
Number of subjects: 18
Study: 19838842

Group type: EXPERIMENTAL
Intervention: IMPACT intervention (n = 112)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Usual care (n = 103)
Number of subjects: 215
Study: 17130571

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 0

Group type: COMPARATOR
Intervention: 400 IU vitamin D3
Number of subjects: 0
Study: 15514280

Group type: EXPERIMENTAL
Intervention: 2 daily servings of soy foods equivalent to 50 mg of isoflavones
Number of subjects: 220

Group type: COMPARATOR
Intervention: Regular diet (Control)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Lifetime soy intake (questionnaire)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Lower soy intake during early life and higher soy intake during adulthood
Number of subjects: 220
Study: 11324215

Group type: EXPERIMENTAL
Intervention: Immediately loaded single-tooth implants in fresh extraction sites
Number of subjects: 26

Group type: COMPARATOR
Intervention: Immediately loaded single-tooth implants in healed sites
Number of subjects: 26
Study: 9560497

Group type: EXPERIMENTAL
Intervention: Double-gloving
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-gloving
Number of subjects: 0
Study: 7930130

Group type: EXPERIMENTAL
Intervention: Study wards
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control wards
Number of subjects: 192
Study: 3124597

Group type: EXPERIMENTAL
Intervention: Preoperative total parenteral nutrition (TPN)
Number of subjects: 0
Study: 30268694

Group type: EXPERIMENTAL
Intervention: CPAP (≥ 4 hours per night)
Number of subjects: 2483

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 2483

Group type: COMPARATOR
Intervention: Standard care alone (Control)
Number of subjects: 2483
Study: 28600913

Group type: EXPERIMENTAL
Intervention: Once-daily SMBG with enhanced patient feedback (automatic tailored messages)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Once-daily SMBG
Number of subjects: 450

Group type: COMPARATOR
Intervention: No SMBG
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: All groups (including no SMBG, once-daily SMBG, and once-daily SMBG with messaging)
Number of subjects: 450
Study: 27107279

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (ten-session group intervention incorporating the Tree of Life narrative approach and constructivist psychoeducation)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 80
Study: 23589107

Group type: EXPERIMENTAL
Intervention: Vaccination with HLA-A*0201-modified tumor peptides and low-dose cyclophosphamide (CTX) and low-dose interleukin-2 (IL-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose CTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaccination with HLA-A*0201-modified tumor peptides
Number of subjects: 0
Study: 20380779

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (STPP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 80
Study: 19395240

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy targeting mental state attribution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy targeting mental flexibility
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 24
Study: 16469146

Group type: EXPERIMENTAL
Intervention: Fermented milk with L. johnsonii La1
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (fermented milk without L. johnsonii La1)
Number of subjects: 22
Study: 15271201

Group type: EXPERIMENTAL
Intervention: Instrument-independent no-scalpel vasectomy (IINSV)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Instrument-dependent no-scalpel vasectomy (IDNSV)
Number of subjects: 449
Study: 11778923

Group type: EXPERIMENTAL
Intervention: Heparin-induced extracorporeal low-density lipoprotein (LDL) precipitation (HELP) apheresis
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional treatment with prednisolone and dextranes for 10 days
Number of subjects: 53
Study: 9140210

Group type: EXPERIMENTAL
Intervention: Vanadyl sulphate treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 7967704

Group type: EXPERIMENTAL
Intervention: Trace element content in hair of aplastic anemia patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal subjects (control)
Number of subjects: 20
Study: 3425385

Group type: EXPERIMENTAL
Intervention: Individual dietary instructions by a nurse
Number of subjects: 80

Group type: COMPARATOR
Intervention: Short, written leaflet given by a doctor
Number of subjects: 80
Study: 30247585

Group type: EXPERIMENTAL
Intervention: Upper medial intergluteal sulcus infiltration at -30°, -10°, and 0° angles
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Middle lower gluteal sulcus infiltration at -30°, 0°, and +15° angles
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Peritrochanteric access at 0° and +10° and middle of the buttock at -30° angle
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Upper medial intergluteal sulcus infiltration without -30° angle
Number of subjects: 10
Study: 27230268

Group type: EXPERIMENTAL
Intervention: Arsenic educational interventions combined with fee-based water arsenic testing programs
Number of subjects: 285

Group type: COMPARATOR
Intervention: Fee-based arsenic testing alone
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Increased instrumental attitude
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Descriptive norm
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Coping planning
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Commitment
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Distance from the nearest arsenic-safe drinking water source
Number of subjects: 285
Study: 25854021

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with ultraviolet therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Medicine group (intravenous acyclovir, muscular cobamamide, topical acyclovir, TDP radiation)
Number of subjects: 34
Study: 24044595

Group type: EXPERIMENTAL
Intervention: Combining behavioral, physical, and psychological criteria for recovery
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Defining recovery with abstinence from binge eating and purging
Number of subjects: 96